Listed by the USPTO as MELCHIOR, JAMES RYLAND
Tech Center 1600 • Art Units: 1642 1644 1645 1658
This examiner grants 62% of resolved cases
MELCHIOR, JAMES RYLAND has 74 resolved cases assigned to art unit 1642 in tech center 1600. The allowance rate is 62.2%, interview lift is 39.5%, and median time to allowance is 1276 days. The limited case volume reduces forecasting certainty, but the available record shows a majority allowance outcome and a substantial association between interviews and allowance. The median timing indicates an extended prosecution path.
The listed companies are Amgen Inc., Janssen Pharmaceuticals Inc., and Genentech Inc. The principal firms are Casimir Jones, S.C., FOLEY & LARDNER LLP, and Hoffmann & Baron LLP. Practitioners may use interviews to address technical and claim-scope issues directly, while preparing written amendments that preserve alternatives for cases likely to require sustained prosecution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18578690 | Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) Antibody-Maytansine Conjugates and Methods of Use Thereof | Non-Final OA | R.P. Scherer Technologies, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.2% of resolved applications examined by James Ryland Melchior were allowed (74 resolved cases), compared with 38.5% across Art Unit 1642 over the last five years.
This examiner's interview lift is +39.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by James Ryland Melchior took 1,276 days on average from filing to allowance.
James Ryland Melchior examines applications in Art Unit 1642 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
